Stille AB (STIL.ST)
SEK 182.0
(-2.15%)
SEK 182.0
(-2.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -178.5 Million SEK | -623.64% |
| 2022 | 34.08 Million SEK | -36.5% |
| 2021 | 53.68 Million SEK | 482.98% |
| 2020 | -14.01 Million SEK | 30.2% |
| 2019 | -20.08 Million SEK | 42.41% |
| 2018 | -34.87 Million SEK | -12.98% |
| 2017 | -30.86 Million SEK | -7.8% |
| 2016 | -28.63 Million SEK | -131.42% |
| 2015 | -12.37 Million SEK | -4399.27% |
| 2014 | -275 Thousand SEK | 95.03% |
| 2013 | -5.53 Million SEK | -212.31% |
| 2012 | 4.93 Million SEK | 180.65% |
| 2011 | 1.75 Million SEK | 241.24% |
| 2010 | -1.24 Million SEK | -71.59% |
| 2009 | -725 Thousand SEK | 75.03% |
| 2008 | -2.9 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -97.87 Million SEK | -7.67% |
| 2024 Q2 | -90.9 Million SEK | -194.07% |
| 2024 Q1 | 96.63 Million SEK | 154.14% |
| 2023 Q3 | 73.83 Million SEK | -4.32% |
| 2023 Q1 | 64.68 Million SEK | 89.74% |
| 2023 Q4 | -178.5 Million SEK | -341.76% |
| 2023 Q2 | 77.16 Million SEK | 19.31% |
| 2023 FY | -178.5 Million SEK | -623.64% |
| 2022 Q2 | 87.96 Million SEK | -6.1% |
| 2022 Q3 | 80.35 Million SEK | -8.65% |
| 2022 Q4 | 34.08 Million SEK | -57.58% |
| 2022 Q1 | 93.67 Million SEK | 74.49% |
| 2022 FY | 34.08 Million SEK | -36.5% |
| 2021 FY | 53.68 Million SEK | 482.98% |
| 2021 Q1 | -3.24 Million SEK | 76.84% |
| 2021 Q2 | 13.21 Million SEK | 507.08% |
| 2021 Q3 | 71.8 Million SEK | 443.2% |
| 2021 Q4 | 53.68 Million SEK | -25.23% |
| 2020 FY | -14.01 Million SEK | 30.2% |
| 2020 Q4 | -14.01 Million SEK | -510.27% |
| 2020 Q3 | -2.29 Million SEK | 66.12% |
| 2020 Q2 | -6.78 Million SEK | 35.47% |
| 2020 Q1 | -10.5 Million SEK | 47.69% |
| 2019 Q1 | -33.49 Million SEK | 3.94% |
| 2019 Q3 | -39.67 Million SEK | -24.05% |
| 2019 Q4 | -20.08 Million SEK | 49.38% |
| 2019 Q2 | -31.98 Million SEK | 4.53% |
| 2019 FY | -20.08 Million SEK | 42.41% |
| 2018 Q2 | -32.39 Million SEK | 9.28% |
| 2018 FY | -34.87 Million SEK | -12.98% |
| 2018 Q4 | -34.87 Million SEK | -29.32% |
| 2018 Q3 | -26.96 Million SEK | 16.75% |
| 2018 Q1 | -35.7 Million SEK | -15.66% |
| 2017 Q3 | -31.82 Million SEK | -16.25% |
| 2017 Q2 | -27.37 Million SEK | 7.36% |
| 2017 Q1 | -29.55 Million SEK | -3.21% |
| 2017 FY | -30.86 Million SEK | -7.8% |
| 2017 Q4 | -30.86 Million SEK | 3.01% |
| 2016 Q2 | -19.51 Million SEK | -4.49% |
| 2016 Q1 | -18.67 Million SEK | -50.96% |
| 2016 FY | -28.63 Million SEK | -131.42% |
| 2016 Q4 | -28.63 Million SEK | -32.66% |
| 2016 Q3 | -21.58 Million SEK | -10.59% |
| 2015 Q2 | -6.18 Million SEK | -111.92% |
| 2015 Q1 | -2.91 Million SEK | -961.45% |
| 2015 FY | -12.37 Million SEK | -4399.27% |
| 2015 Q4 | -12.37 Million SEK | -9.85% |
| 2015 Q3 | -11.26 Million SEK | -82.09% |
| 2014 Q3 | 2.7 Million SEK | 790.54% |
| 2014 Q2 | -391 Thousand SEK | 83.55% |
| 2014 Q1 | -2.37 Million SEK | 57.08% |
| 2014 FY | -275 Thousand SEK | 95.03% |
| 2014 Q4 | -275 Thousand SEK | -110.19% |
| 2013 Q2 | 5.88 Million SEK | 1.75% |
| 2013 Q1 | 5.78 Million SEK | 17.36% |
| 2013 FY | -5.53 Million SEK | -212.31% |
| 2013 Q3 | -3.83 Million SEK | -165.17% |
| 2013 Q4 | -5.53 Million SEK | -44.33% |
| 2012 Q2 | 8.24 Million SEK | -5.25% |
| 2012 Q1 | 8.7 Million SEK | 395.22% |
| 2012 Q3 | 7.35 Million SEK | -10.82% |
| 2012 Q4 | 4.93 Million SEK | -32.93% |
| 2012 FY | 4.93 Million SEK | 180.65% |
| 2011 Q2 | -3.48 Million SEK | -562.86% |
| 2011 Q1 | -525 Thousand SEK | 57.8% |
| 2011 FY | 1.75 Million SEK | 241.24% |
| 2011 Q3 | -1.54 Million SEK | 55.55% |
| 2011 Q4 | 1.75 Million SEK | 213.57% |
| 2010 Q1 | 1.04 Million SEK | 244.55% |
| 2010 FY | -1.24 Million SEK | -71.59% |
| 2010 Q4 | -1.24 Million SEK | -182.82% |
| 2010 Q3 | 1.5 Million SEK | -12.32% |
| 2010 Q2 | 1.71 Million SEK | 63.45% |
| 2009 FY | -725 Thousand SEK | 75.03% |
| 2009 Q4 | -725 Thousand SEK | 0.0% |
| 2009 Q2 | 2.11 Million SEK | -28.97% |
| 2009 Q1 | 2.98 Million SEK | 0.0% |
| 2008 FY | -2.9 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | -407.849% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 114.549% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 114.549% |
| Arcoma AB | -1.12 Million SEK | -15724.823% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 262.451% |
| BICO Group AB (publ) | 927.9 Million SEK | 119.237% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 238.59% |
| CellaVision AB (publ) | -56.94 Million SEK | -213.484% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | -1099.866% |
| Chordate Medical Holding AB (publ) | -8.45 Million SEK | -2011.172% |
| C-Rad AB (publ) | -127.6 Million SEK | -39.893% |
| Duearity AB (publ) | 10.23 Million SEK | 1844.737% |
| Dignitana AB (publ) | 13.07 Million SEK | 1465.023% |
| Episurf Medical AB (publ) | -52.7 Million SEK | -238.717% |
| Getinge AB (publ) | 5.4 Billion SEK | 103.301% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | -409.239% |
| Iconovo AB (publ) | -10.75 Million SEK | -1559.679% |
| Integrum AB (publ) | -10.47 Million SEK | -1603.846% |
| Luxbright AB (publ) | -13.83 Million SEK | -1190.378% |
| Mentice AB (publ) | -49.56 Million SEK | -260.148% |
| OssDsign AB (publ) | -162.78 Million SEK | -9.654% |
| Paxman AB (publ) | -11.41 Million SEK | -1464.315% |
| Promimic AB (publ) | -50.32 Million SEK | -254.717% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 1036.046% |
| SciBase Holding AB (publ) | -27.32 Million SEK | -553.286% |
| ScandiDos AB (publ) | -1.53 Million SEK | -11559.308% |
| Sectra AB (publ) | -772.85 Million SEK | 76.903% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 21.32% |
| Senzime AB (publ) | -139.54 Million SEK | -27.922% |
| SpectraCure AB (publ) | -50.23 Million SEK | -255.345% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 114.536% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 16.84% |